Dataset opportunity
Cosinuss — Developer Data Platform Opportunity
Large developer data platform held by Cosinuss, usable for Document Intelligence and RAG.
Score
76.3
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
89%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI in clinical documentation market = $2.03B in 2026, CAGR 31.4% (2026-2035)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
More Americans own wearables, connected health devices: survey
medtechdive.com ↗ - 📰press2026-06-04
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
medtechdive.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-03
Edwards gets FDA approval for surgical tricuspid valve
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 🧑💻Hiring a data role
Team Lead for Data Science, Research and Machine Learning (Dr. Michael Weber)
source ↗ - 🧑💻Hiring a data role
Data Scientist (Axel Heinrich)
source ↗ - 📦Data product
Data Analytics page and cosinuss° Health Platform for data interpretation
source ↗ - 🔌Public API
Developer SDK with REST API for raw data connection
source ↗ - 📝Published article
cosinuss° in Research section highlighting publications and studies
source ↗
Profile
Dataset profile
Type
Developer Data Platform
Modality
Multimodal
Sector
healthcare
Volume
Large
Freshness
Real-time
Rarity
Medium
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Document-AI / IDP vendors
Cosinuss possesses a rich Developer Data Platform offering multimodal data, including medical records, IoT data from certified devices, event streams, and a knowledge base. This comprehensive dataset is highly valuable for Document Intelligence applications, enabling the training of AI models to extract, classify, and analyze critical information from diverse healthcare documents and data streams.
Despite the inherent complexities such as GDPR-sensitive information, the need for regulatory compliance due to medically certified devices, and potential client ownership or usage agreements, this data remains exceptionally valuable. The market for AI in clinical documentation is experiencing rapid growth, underscoring the demand for such specialized and high-quality healthcare data. ⚠ Diligence (valuable data, access to negotiate): Data is health-related and GDPR-sensitive.; Company is a subsidiary, requiring coordination with parent company Corpuls.; Data may be subject to client (patient/hospital) ownership or usage agreements.; Medically certified device and data, implying strict regulatory compliance. · corporate: subsidiary of Corpuls.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
Cosinuss possesses a robust Developer Data Platform offering a unique blend of multimodal data, including raw physiological time-series from in-ear wearable sensors and comprehensive regulatory-compliant documentation. This rich dataset is exceptionally valuable for Document-AI / IDP vendors aiming to innovate within the burgeoning AI in clinical documentation market, projected to reach $2.03B by 2026. Access to both real-time sensor data and structured operational documents provides a critical foundation for developing advanced Document Intelligence solutions, enabling AI to accurately interpret complex healthcare information and accelerate clinical workflows.
See dimension details ↓- Dataset Specificity90
dominant 'developer_portal', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
proprietary domain data (open lowers rarity)
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume100
13 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Document Intelligence
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
The global healthcare intelligent document processing market size is estimated to grow at a compound annual growth rate (CAGR) of 33.3% from 2024 to 2030, reflecting a strong demand for data and platforms in this sector for AI applications.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility26
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility35
high difficulty, subsidiary of Corpuls
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength100
7 evidence types, 13 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of Corpuls
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation90
5 data-appetite signals (4 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
⚠ review — Cosinuss is a medical technology company that develops and sells in-ear sensors and a comprehensive monitoring system, including data acquisition, analysis, and insights, indicating their core business already involves selling intelligence derived from data. Issues: Cosinuss's core business is selling a vital signs monitoring solution that explicitly includes data acquisition, transmission, access, and analysis, providing i; They offer 'Data analysis' with 'powerful algorithms and ind
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Developer portal
This evidence confirms Cosinuss maintains a developer portal with comprehensive regulatory-compliant documentation, crucial for AI buyers needing to understand data governance and integrate within a healthcare context.
IoT / sensor data
This data type reveals Cosinuss collects raw physiological time-series data from wearable medical devices, offering high-fidelity insights into patient vital signs for advanced healthcare analytics.
Downloads / exports
This indicates the availability of structured documents like job descriptions, suggesting a broader repository of PDF-based operational data valuable for document processing AI.
Knowledge base / docs
This highlights extensive textual documentation detailing regulatory compliance and technical architecture, providing essential context for AI models processing healthcare-specific information.
Medical records / imaging
This suggests the presence of patient monitoring data, potentially in image format, which is vital for AI systems analyzing clinical observations and vital sign trends.
API access
This confirms a Developer SDK and API access to raw sensor data with technical documentation, enabling seamless integration for AI applications requiring real-time data streams.
Event streams
This specifically identifies raw PPG signal data as an event stream, providing continuous, high-resolution physiological measurements critical for real-time health monitoring AI.
Coverage
Scanned sources
Deliverable
Premium dataset report
Cosinuss Developer Data Platform — a Large developer data platform (Multimodal modality) in the healthcare domain. Primary AI use-case: Document Intelligence. Market signal: Global AI in clinical documentation market = $2.03B in 2026, CAGR 31.4% (2026-2035). Investment score 76.3/100 (confidence 0.89). Recommended action: Data Sharing Agreement.